Ondrej Ballek

Ondrej Ballek

Auto-generated profile, based on publicly available information

Ondrej Ballek

Laboratory of Immunobiology, Institute of Molecular Genetics of the Czech Academy of Sciences

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JBJiří Březina
Jiří Březina
TBTomáš Brabec
Tomáš Brabec
DMDavid Machač
David Machač
MVMatouš Vobořil
Matouš Vobořil
OBOndřej Ballek
Ondřej Ballek
DFDominik Filipp
Dominik Filipp
Central tolerance, which relies on the presentation of self-antigens by mTECs and DCs, prevents autoimmunity by eliminating self-reactive T cells. While mTECs produce self-antigens autonomously, DCs acquire them from mTECs via cooperative antigen transfer (CAT). We previously showed that mTEC and DC subsets exhibit preferential pairing in CAT, providing a rationale for the existence of molecular determinants underpinning this pairing and its outcome. Here, we compared the transcriptomes of CAT-experienced and CAT-inexperienced DCs and identified Claudin 1 as a molecule involved in CAT and type 1 DC (DC1) maturation. DC1-specific ablation of Claudin 1 resulted in decreased CAT to late mature DC1s and dramatically diminished DC1 maturation. These phenotypes correlated with the displacement of DC1s from mTECs and their decreased expression of MHCII pathway genes. This translated into impaired Treg selection and clonal deletion, ultimately manifesting in symptoms of multiorgan autoimmunity and shortened lifespan. Collectively, our results identify thymic DC1-derived Claudin 1 as a regulator of immune tolerance.

29 September 2026 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PLPavlina Laskova
Pavlina Laskova
SPStanislava Porkertova
Stanislava Porkertova
OBOndrej Ballek
Ondrej Ballek
LBLucie Balonova
Lucie Balonova
JPJana Pavloskova
Jana Pavloskova
MLMarek Link
Marek Link
Human tularemia is caused by infection with the intracellular bacterium Francisella tularensis . The ability of the bacterium to cause a severe pneumonic form of the disease has led to concerns in the field of biodefense and efforts to develop a vaccine. F. tularensis LVS provides partial protection against fully virulent strains, with CD4 + T cells playing a significant role in this protection, however the recognized bacterial antigens remain largely unknown. To identify these antigens, we screened MHC class II peptides presented by infected dendritic cells using mass spectrometry-based immunopeptidomics. We identified 57 MHC-II peptides from 23 different F. tularensis LVS proteins. Most of these proteins were highly expressed in the bacterial proteome. Subsequent screening for IFN-γ responses identified ten peptides as immunogenic epitopes of CD4 + T cells following immunization of mice with F. tularensis LVS, thereby revealing previously unknown specificity and breadth of the induced immune responses. Five epitopes, derived from the antigens FTL_1678, DacD, DnaK, FTL_1498, and MinD, represented the dominant epitopes that elicited a response in at least 80% of immunizations. Finally, a peptide vaccine containing these epitopes proved to be immunogenic in mice and contributed to the early control of bacterial replication following challenge with the virulent F. tularensis FSC200 strain, although this alone was insufficient to ensure complete protection. Using immunopeptidomics, we have thus identified several immunogenic CD4 + T cell epitopes and antigens of F. tularensis LVS. Beyond their potential role in the protective immune response, the identified epitopes may also enable the development of tools for characterizing antigen-specific CD4 + T cells in vaccination studies or T cell biology research.